Humira (AbbVie Inc.)
Welcome to the PulseAid listing for the Humira drug offered from AbbVie Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AbbVie Inc. |
NON-PROPRIETARY NAME: | Adalimumab |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2016-10-17 |
END MARKETING DATE: | 0000-00-00 |
Humira HUMAN PRESCRIPTION DRUG Details:
Item Description | Humira from AbbVie Inc. |
LABELER NAME: | AbbVie Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2016-10-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0074-0067_45805ad6-c43a-4b70-7d7c-d476cf5116b9 |
PRODUCT NDC: | 0074-0067 |
APPLICATION NUMBER: | BLA125057 |